These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

495 related items for PubMed ID: 8666777

  • 1. Adoptively transferred CD4+ lymphocytes from CD8 -/- mice are sufficient to mediate the rejection of MHC class II or class I disparate skin grafts.
    Dalloul AH, Chmouzis E, Ngo K, Fung-Leung WP.
    J Immunol; 1996 Jun 01; 156(11):4114-9. PubMed ID: 8666777
    [Abstract] [Full Text] [Related]

  • 2. CD4-negative cytotoxic T cells with a T cell receptor alpha/beta intermediate expression in CD8-deficient mice.
    Dalloul AH, Ngo K, Fung-Leung WP.
    Eur J Immunol; 1996 Jan 01; 26(1):213-8. PubMed ID: 8566069
    [Abstract] [Full Text] [Related]

  • 3. Allograft rejection in athymic nude rats by transferred T cell subsets. II. The response of naive CD4+ and CD8+ thoracic duct lymphocytes to an isolated MHC class I disparity.
    Bell EB, Rejali D, Whitby EH, Sparshott SM, Yang CP.
    Transplantation; 1990 Oct 01; 50(4):690-6. PubMed ID: 1977220
    [Abstract] [Full Text] [Related]

  • 4. IL-5 mediates eosinophilic rejection of MHC class II-disparate skin allografts in mice.
    Le Moine A, Surquin M, Demoor FX, Noël JC, Nahori MA, Pretolani M, Flamand V, Braun MY, Goldman M, Abramowicz D.
    J Immunol; 1999 Oct 01; 163(7):3778-84. PubMed ID: 10490975
    [Abstract] [Full Text] [Related]

  • 5. Rejection of skin allografts by CD4+ T cells is antigen-specific and requires expression of target alloantigen on Ia- epidermal cells.
    Rosenberg AS, Katz SI, Singer A.
    J Immunol; 1989 Oct 15; 143(8):2452-6. PubMed ID: 2477443
    [Abstract] [Full Text] [Related]

  • 6. Tumor allograft rejection is mainly mediated by CD8+ cytotoxic T lymphocytes stimulated with class I alloantigens in cooperation with CD4+ helper T cells recognizing class II alloantigens.
    Tomita Y, Mayumi H, Eto M, Nomoto K.
    J Immunol; 1990 Mar 15; 144(6):2425-35. PubMed ID: 1968930
    [Abstract] [Full Text] [Related]

  • 7. NK cells contribute to the skin graft rejection promoted by CD4+ T cells activated through the indirect allorecognition pathway.
    Ito A, Shimura H, Nitahara A, Tomiyama K, Ito M, Kanekura T, Okumura K, Yagita H, Kawai K.
    Int Immunol; 2008 Oct 15; 20(10):1343-9. PubMed ID: 18697765
    [Abstract] [Full Text] [Related]

  • 8. Some cloned murine CD4+ T cells recognize H-2Ld class I MHC determinants directly. Other cloned CD4+ T cells recognize H-2Ld class I MHC determinants in the context of class II MHC molecules.
    McKisic MD, Sant AJ, Fitch FW.
    J Immunol; 1991 Nov 01; 147(9):2868-74. PubMed ID: 1717578
    [Abstract] [Full Text] [Related]

  • 9. Acute rejection of orthotopic corneal xenografts in mice depends on CD4(+) T cells and self-antigen-presenting cells.
    Tanaka K, Sonoda K, Streilein JW.
    Invest Ophthalmol Vis Sci; 2001 Nov 01; 42(12):2878-84. PubMed ID: 11687532
    [Abstract] [Full Text] [Related]

  • 10. Peptides derived from alpha-helices of allogeneic class I major histocompatibility complex antigens are potent inducers of CD4+ and CD8+ T cell and B cell responses after cardiac allograft rejection.
    Shirwan H, Leamer M, Wang HK, Makowka L, Cramer DV.
    Transplantation; 1995 Feb 15; 59(3):401-10. PubMed ID: 7871571
    [Abstract] [Full Text] [Related]

  • 11. Prolonged allograft survival in anti-CD4 antibody transgenic mice: lack of residual helper T cells compared with other CD4-deficient mice.
    Han WR, Zhan Y, Murray-Segal LJ, Brady JL, Lew AM, Mottram PL.
    Transplantation; 2000 Jul 15; 70(1):168-74. PubMed ID: 10919596
    [Abstract] [Full Text] [Related]

  • 12. CD4+ T cell-mediated rejection of major histocompatibility complex class I-disparate grafts: a role for alloantibody.
    Morton AL, Bell EB, Bolton EM, Marshall HE, Roadknight C, McDonagh M, Bradley JA.
    Eur J Immunol; 1993 Sep 15; 23(9):2078-84. PubMed ID: 8103742
    [Abstract] [Full Text] [Related]

  • 13. Adoptive immunity in immune-deficient scid/scid mice. I. Differential requirements of naive and primed lymphocytes for CD4+ T cells during rejection of minor histocompatibility antigen-disparate skin grafts.
    Roopenian DC, Anderson PS.
    Transplantation; 1988 Dec 15; 46(6):899-904. PubMed ID: 2905088
    [Abstract] [Full Text] [Related]

  • 14. A synthetic CD4-CDR3 peptide analog enhances skin allograft survival across a MHC class II barrier.
    Koch U, Choksi S, Marcucci L, Korngold R.
    J Immunol; 1998 Jul 01; 161(1):421-9. PubMed ID: 9647252
    [Abstract] [Full Text] [Related]

  • 15. An immunodominant minor histocompatibility alloantigen that initiates corneal allograft rejection.
    Haskova Z, Sproule TJ, Roopenian DC, Ksander AB.
    Transplantation; 2003 Apr 27; 75(8):1368-74. PubMed ID: 12717232
    [Abstract] [Full Text] [Related]

  • 16. Carcinogen-treated skin allografts rejected by T lymphocytes specific for class I but not class II MHC antigens.
    Halliday GM, Odling KA, Muller HK.
    Cell Immunol; 1993 Oct 15; 151(2):291-9. PubMed ID: 8402936
    [Abstract] [Full Text] [Related]

  • 17. Pathways of helper CD4 T cell allorecognition in generating alloantibody and CD8 T cell alloimmunity.
    Taylor AL, Negus SL, Negus M, Bolton EM, Bradley JA, Pettigrew GJ.
    Transplantation; 2007 Apr 15; 83(7):931-7. PubMed ID: 17460565
    [Abstract] [Full Text] [Related]

  • 18. Comparison of Abeta(b-/-), H2-DM(-), and CIITA(-/-) in second-set skin allograft rejection.
    Felix NJ, de Serres S, Meyer AA, Ting JP.
    J Surg Res; 2002 Feb 15; 102(2):185-92. PubMed ID: 11796017
    [Abstract] [Full Text] [Related]

  • 19. Mechanism of allorecognition and skin graft rejection in CD28 and CD40 ligand double-deficient mice.
    Habiro K, Kotani M, Omoto K, Kobayashi S, Tanabe K, Shimmura H, Suzuki K, Hayashi T, Toma H, Abe R.
    Transplantation; 2003 Sep 15; 76(5):854-8. PubMed ID: 14501867
    [Abstract] [Full Text] [Related]

  • 20. Role of CD4+ and CD8+ T cells in murine skin and heart allograft rejection across different antigenic desparities.
    Youssef AR, Otley C, Mathieson PW, Smith RM.
    Transpl Immunol; 2004 Dec 15; 13(4):297-304. PubMed ID: 15589743
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 25.